Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$19.43 USD
+6.92 (55.32%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $19.00 -0.43 (-2.21%) 4:44 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -2.13 |
EPS Last Quarter | 0.75 |
Last EPS Surprise | 118.75% |
ABR | 1.00 |
Earnings ESP
|
-106.25% |
---|---|
Current Year | -8.15 |
Next Year | -12.43 |
EPS (TTM) | -20.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00M | 1.00M | 2.70M | 4.00M |
# of Estimates | 1 | 1 | 3 | 1 |
High Estimate | 1.00M | 1.00M | 4.00M | 4.00M |
Low Estimate | 1.00M | 1.00M | 2.05M | 4.00M |
Year ago Sales | 2.15M | 2.68M | 14.44M | 2.70M |
Year over Year Growth Est. | -53.49% | -62.69% | -81.31% | 48.15% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.13 | -1.47 | -8.15 | -12.43 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -4.40 | -2.41 | -11.21 | -11.28 |
High Estimate | 0.50 | -0.25 | -4.50 | -8.50 |
Low Estimate | -4.40 | -2.41 | -11.21 | -17.50 |
Year ago EPS | -10.25 | -5.50 | -34.00 | -8.15 |
Year over Year Growth Est. | 79.22% | 73.27% | 76.03% | -52.44% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.13 | -1.47 | -8.15 | -12.43 |
7 Days Ago | -2.13 | -1.47 | -8.15 | -12.43 |
30 Days Ago | -1.00 | -1.00 | -6.63 | -13.00 |
60 Days Ago | -4.25 | -4.50 | -18.25 | -17.75 |
90 Days Ago | -4.25 | -4.50 | -18.25 | -17.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -4.40 | -2.41 | -11.21 | -11.28 |
Zacks Consensus Estimate | -2.13 | -1.47 | -8.15 | -12.43 |
Earnings ESP | -106.25% | -63.95% | -37.49% | 9.23% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.75 | -5.50 | -5.50 | -10.25 | NA |
Estimate | -4.00 | -4.75 | -6.75 | -12.00 | NA |
Difference | 4.75 | -0.75 | 1.25 | 1.75 | 1.75 |
Surprise | 118.75% | -15.79% | 18.52% | 14.58% | 34.02% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more